Serotonin and Noradrenaline Reuptake Inhibitors: all 504 studies that test it
Page 4 of 6. Open to participants first (35), then studies with results posted, then the rest; newest registration first within each.
- Results From a 24 Week Trial of EMDR Combined With Venlafaxine XRWithdrawnNCT02433353Phase 4
- Pharmacovigilance in Gerontopsychiatric PatientsTerminatedNCT02374567Phase 3
- Prospective RCT on Post Prostatectomy Urine LeakStatus unknownNCT02367404Phase 3
- Effect of Preoperative Duloxetine on Quality of Recovery After Outpatient Laparoscopic SurgeryWithdrawnNCT02351440Phase 4
- Comparison of Propranolol and Venlafaxine in Treatment of Vestibular MigraineCompletedNCT02350985Phase 4
- Neurochemical, Metabonomics and Neuroimaging Characterization of TCM Diagnostic Subtypes of Major Depression DisorderStatus unknownNCT02346682Phase 4
- Prediction of Antidepressant Treatment Response Using Machine Learning Classification AnalysisStatus unknownNCT02330679Phase 4
- Does Duloxetine Reduce Chronic Pain After Total Knee Arthroplasty?Status unknownNCT02307305Phase 2
- Bioavailability Study of Duloxetine Delayed-Release Capsules 60 mg Under Fasting ConditionCompletedNCT02291367Phase 1
- Bioavailability Study of Duloxetine Delayed-Relase Capsules 60 mg Under Fed ConditionCompletedNCT02291341Phase 1
- Effect of F2695 on Brain Activity Measured by Functional Magnetic Resonance ImagingCompletedNCT02266966Phase 1
- Optimizing Antidepressant Treatment by Genotype-dependent Adjustment of Medication According to the ABCB1 GeneStatus unknownNCT02237937Phase 4
- Study to Evaluate the Efficacy of Duloxetine in Outpatients With Major Depressive Disorder and PainCompletedNCT02232555Phase 3
- Imaging Pain Relief in OsteoarthritisCompletedNCT02208778Phase 4
- Desvenlafaxine in Opioid-Dependent PatientsCompletedNCT02200406Phase 4
- Antidepressants and Bone Mineral DensityCompletedNCT02179268Phase 3
- A Phase 1, Drug Interaction Study Between AVP-786 and Paroxetine and Between AVP-786 and Duloxetine in Healthy SubjectsCompletedNCT02174822Phase 1
- Beta-arrestins and Response to Venlafaxine in Major Depressive Disorder (MDD) (DEPARRESTCLIN)CompletedNCT02051413Phase 4
- Pain Prevention and Treatment Through the Enhancement of the Anti-nociceptive Component of Pain Modulation ProfilesCompletedNCT02020122Not applicable
- Venlafaxine PK Following Bariatric SurgeryCompletedNCT02005107Phase 4
- Efficacy of SNRI Treatment on Prefrontality in Patients With GAD and Other ComorbitiesCompletedNCT01975480Phase 4
- Efficacy and Safety Study of Desvenlafaxine in the Treatment of Vascular DepressionStatus unknownNCT01974934Phase 4
- Desvenlafaxine Monotherapy in DysthymiaCompletedNCT01948895Not applicable
- Study to Examine the Effect of Gastric Bypass Surgery on Venlafaxine ER Blood LevelsCompletedNCT01867255Phase 1
- Comparison of Venlafaxine and Fluoxetine in the Treatment of Postmenopausal Women With Major DepressionCompletedNCT01824433Phase 4
- Prospective Study of the Influence of the Diffuse Noxious Inhibitory Controls of the Pain on the Efficacy of Milnacipran in Fibromyalgia TherapyStatus unknownNCT01747044Phase 2
- Healing With Venlafaxine After Injury (HELP)CompletedNCT01716377Phase 2
- Mechanisms of Neuromuscular Fatigue Post StrokeCompletedNCT01688570Early Phase 1
- Study of Placebo Without Deception Versus Standard Antidepressant for Major Depressive DisorderTerminatedNCT01650740Not applicable
- Effect of F2695 on Functional Recovery After Ischemic StrokeCompletedNCT01639014Phase 3
- Cymbalta for Fibromyalgia Pain - Predictive Value of Small Fiber ChangedWithdrawnNCT01619566Phase 4
- The Treatment of Traumatised Refugees With Sertraline Versus Venlafaxine in Combination With PsychotherapyCompletedNCT01569685Phase 4
- Functional Outcome in Postpartum Depression in Women Treated With DesvenlafaxineCompletedNCT01527786Phase 3
- Bioavailability Study of Venlafaxine MR Capsules 150 mg Under Fed ConditionsCompletedNCT01512459Phase 1
- Evaluation of the Role of the Noradrenergic System in Pain Perception in Parkinson's DiseaseCompletedNCT01504178Phase 3
- Effect of Antidepressants on White Matter StructureStatus unknownNCT01492621Phase 4
- Multiparametric MRI Study of Endogenous Analgesia and Prediction the Efficacy of Migraine Pharmacological PreventionCompletedNCT01470352Not applicable
- Improvement the Anti-migraine Treatment Efficacy by Tailoring the Drug to Individual's Pain Modulation ProfileCompletedNCT01470339Not applicable
- Neurocognition and Work Productivity in Major Depressive Disorder (MDD)CompletedNCT01468610Not applicable
- Effect of Duloxetine and Venlafaxine on the Pharmacokinetics and Pharmacodynamics of Oral Tramadol: A Three-phase Randomized Balanced Cross-over Study in Healthy VolunteersCompletedNCT01443520Phase 4
- Pharmacokinetics and Safety of Desvenlafaxine in Korean Healthy Subjects Following Single and Multiple Oral Doses of Desvenlafaxine Succinate Sustained Release TabletCompletedNCT01443208Phase 1
- Duloxetine for Pain in Older Adults With Knee Osteoarthritis (OA)CompletedNCT01425827Not applicable
- Efficacy and Safety of Milnacipran in the Treatment of Fibromyalgia in an Elderly PopulationTerminatedNCT01418651Phase 3
- Bioequivalence Study of Torrent Pharmaceutical Limited's Venlafaxine Hydrochloride ER Capsules Under Fed ConditionsCompletedNCT01418625Phase 1
- Predicting Medication Response in Obsessive Compulsive DisorderCompletedNCT01404871Not applicable
- Inflammatory Markers and Cognitive Function in Major DepressionStatus unknownNCT01391221Phase 4
- Pretreatment Identification of Duloxetine Success in Neuropathic Pain PatientsCompletedNCT01363284Not applicable
- The Effect of Milnacipran on Fatigue and Quality of Life in Lupus PatientsWithdrawnNCT01359826Phase 4
- Mechanism-based Choice of Therapy for Neuropathic PainCompletedNCT01359514Not applicable
- Effects of Antidepressant on Postsynaptic Signal Transduction in Serotonergic System of Depressed PatientsStatus unknownNCT01352572Not applicable
- Prediction of Antidepressant Response Using Pharmacogenetics and Peripheral Lymphocytic PhenotypeStatus unknownNCT01352559Not applicable
- Study to Evaluate the Efficacy of Milnacipran in the Treatment of Pain Due to OsteoarthritisStatus unknownNCT01329406Phase 4
- Preventive Treatment of Episodic and Chronic MigraineStatus unknownNCT01319825Phase 4
- Long-Term Safety Of DVS-233 SR In Patients With Major Depressive DisorderCompletedNCT01309542Phase 3
- Effects of Milnacipran on Widespread Mechanical and Thermal Hyperalgesia of Fibromyalgia PatientsCompletedNCT01294059Phase 1
- "MILNACIPRAN" in Subjects With Chronic Shoulder PainCompletedNCT01289236Phase 4
- Study of Duloxetine in the Reduction of Pain in Patient With Systemic Lupus ErythematosusCompletedNCT01269866Not applicable
- Mechanism-based Choice of Therapy: Can Treatments Success in Fibromyalgia Patients be Coupled to Psychophysical Pain Modulation Profile?Status unknownNCT01268631Not applicable
- Pain Assessment and Quality of Life in Back Pain Patients: Role of MilnacipranWithdrawnNCT01221740Phase 3
- Pharmacogenomics Studies of AntidepressantsStatus unknownNCT01204086Phase 4
- Comparison of the Efficacy of Duloxetine With Placebo in Patients With Chronic Low Back Pain With a Radicular ComponentCompletedNCT01166048Phase 4
- Study to Assess Mechanisms in Peripheral Tissue Innervation for FibromyalgiaCompletedNCT01127490Not applicable
- Study of Fibromyalgia Treated With MilnacipranCompletedNCT01125423Phase 4
- Efficacy, Safety, Tolerability and Pharmacokinetics of Concomitant Administration of Tramadol With Duloxetine or PregabalinWithdrawnNCT01116531Phase 4
- Effectiveness of the Dual Serotonin Norepinephrine Reuptake Inhibitor Desvenlafaxine Succinate in Healthy VolunteersStatus unknownNCT01101152Phase 1
- A Study for Adolescents With Fibromyalgia SyndromeWithdrawnNCT01089621Phase 4
- Trial for Antidepressant Treatment for Negative Symptom of Schizophrenia With NRG1 Risk GenotypeStatus unknownNCT01078870Phase 4
- Safety Study of F2695 SR in Major Depressive DisorderCompletedNCT01034267Phase 3
- Treatment of Hot Flushes Caused by Leuprorelin 11.25 mg in Prostate AdenocarcinomaCompletedNCT01011751Phase 3
- Venlafaxine and Hypnosis or Focused Attention in Treating Patients with Hot FlashesCompletedNCT01000623Not applicable
- Interaction Between Duloxetine and 3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy)CompletedNCT00990067Phase 1
- The Early Medication Change (EMC) TrialCompletedNCT00974155Phase 4
- Population Pharmacokinetic-pharmacodynamic (PK-PD) Modeling of Co-administered Gabapentin in Neuropathic PainCompletedNCT00967707Phase 2
- Pilot Study of Duloxetine in Adult Attention Deficit Hyperactivity Disorder(ADHD)CompletedNCT00940693Phase 2
- A Study to Evaluate the Pharmacokinetics of Duloxetine in Chinese Han Healthy SubjectsCompletedNCT00933452Phase 1
- Assessment of Cognitive Functioning Before and After Treatment With DuloxetineCompletedNCT00933439Not applicable
- Duloxetine for Major Depression in Peri-/Postmenopausal WomenStatus unknownNCT00889369Phase 4
- Desvenlafaxine Succinate (DVS) for Major Depressive Disorder (MDD) in Midlife Men and WomenStatus unknownNCT00888862Phase 3
- Study Evaluating Effexor XR in Chinese Subjects With Major Depressive DisorderWithdrawnNCT00878748Phase 4
- A Relative Bioavailability Study of 50 mg Venlafaxine Hydrochloride Tablets Under Fed ConditionsCompletedNCT00871364Phase 1
- Study Evaluating the Safety, Tolerability and Pharmacokinetics of Desvenlafaxine Succinate SR in Healthy Chinese Male and FemalesCompletedNCT00818155Phase 1
- Physiologic Monitoring of Antidepressant ResponseCompletedNCT00792168Phase 4
- Effects of Duloxetine on Fear Conditioning in Posttraumatic Stress Disorder (PTSD)CompletedNCT00763178Early Phase 1
- Physiologic Monitoring of Antidepressant Treatment ResponseCompletedNCT00759317Phase 4
- Electroencephalography (EEG) Biomarkers of Response in DepressionCompletedNCT00759122Phase 4
- FMS European Long-Term StudyCompletedNCT00757731Phase 3
- Evaluation of the Antinociceptive and Analgesic Effects of MilnacipranCompletedNCT00757679Phase 2
- International Study to Predict Optimised Treatment - in DepressionStatus unknownNCT00693849Phase 4
- Comparison of the Pharmacokinetics of Two Generic Antidepressants and Their Respective Brand PreparationsCompletedNCT00676039Phase 1
- The Role of Central Serotonergic and Adrenergic Systems in the Effectiveness of DNIC (Diffuse Noxious Inhibitory ControlCompletedNCT00660751Not applicable
- Cymbalta for Depression as a Complication of BereavementStatus unknownNCT00658931Phase 4
- Antidepressant Therapy for Bipolar II Major DepressionCompletedNCT00641927Phase 4
- Duloxetine for the Treatment of Postpartum DepressionWithdrawnNCT00617045Not applicable
- A Single-Blind Placebo Run-In Study of Venlafaxine for Activity-Limiting Osteoarthritis PainCompletedNCT00611676Phase 4
- A Single-Blind Placebo Run-in Study of Duloxetine for Activity-Limiting Osteoarthritis PainCompletedNCT00609557Phase 4
- Dose Milnacipran Prevent Depressive Symptoms in Patients With Acute Stroke?Status unknownNCT00606203Not applicable
- Getting Biased Treatment Study: How Psychotherapy and Antidepressants Change Brain Activity in Chronic DepressionStatus unknownNCT00596986Not applicable
- Open-Label Duloxetine Monotherapy in the Treatment of Posttraumatic Stress DisorderStatus unknownNCT00583193Phase 3
- Pilot, Opened, Randomized Clinical Trial to Assess the Efficacy of Duloxetine in the Treatment of Fibromialgy in Patients With Infection by HIV 1+CompletedNCT00552682Phase 3
- Study Evaluating Venlafaxine Extended-Release in Depressed and Anxious PatientsCompletedNCT00546923Phase 4